Globe Life (GL) and MetLife (MET) on Torvanta's measures: GL grades higher on 1 of the 4 factor families and MET on 2.
| GL | MET | |
|---|---|---|
| Value grade | B+ | B+ |
| Growth grade | C- | C |
| Profitability grade | B- | C+ |
| Momentum grade | B- | A |
| Market value | $13.0B | $64.0B |
| P/E (trailing) | 11.2x | 19.3x |
| Forward P/E (Torvanta model estimate) | Subscribers | Subscribers |
| Revenue, last 12 months | $6.2B | $79.4B |
| Revenue growth (y/y) | +5% | +9% |
| Operating margin | n/a | 8.3% |
| Return on invested capital | n/a | 57.4% |
| Free-cash-flow yield | 9.5% | 24.3% |
| Total return, 1 year | +27.3% | +33.1% |
| Total return, 3 years | +50.5% | +73.8% |
Full GL analysis · Full MET analysis
Globe Life (GL) and MetLife (MET) on Torvanta's measures: GL grades higher on 1 of the 4 factor families and MET on 2. Which fits an investor depends on their goals; this is research, not a recommendation. Subscribers see where the model ranks each and its expected return.
On trailing earnings GL trades at 11.2x and MET at 19.3x; their value grades are B+ and B+ against their sectors.
Subscribers get a rating, a fair value estimate, a 12-month target and a risk read for every S&P 500 company, Torvanta's earnings estimates, and three model portfolios (Active, Adaptive and Patient) with every trade sized and explained. A free account includes 3 full Stock Analyst reports a month.
See plans Or get the free weekly newsletterTorvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.
All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer